| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 59.700 | 20140331, Rockmann H
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | Austria | IgE | 35 | 100.000 | 20141020, Guhsl EE
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 22.860 | 20130111, Ott H
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 30.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 31.430 | 20130605, Simon D
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 20 | 95.000 | 20130401, Berneder M
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 6.740 | 20120528, Patelis A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 65.660 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 27.080 | 20120528, Patelis A
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 7.400 | 20120726, Pedrosa M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 10.900 | 20120726, Pedrosa M
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Netherlands | IgE | 41 | 80.490 | 20120905, Le TM
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 1084 | 52.210 | 20110211, DAvino R
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Italy | IgE | 214 | 97.660 | 20110211, DAvino R
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Austria | IgE | 60 | 98.330 | 20110211, DAvino R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 4.240 | 20100301, Scala E
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 91.890 | 20090826, Ebo DG
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 18.180 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 0.000 | 20090808, Krause S
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 65.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 50.000 | 20091005, Ott H
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2006 | Spain / Italy | IgE | 28 | 53.600 | 20060426, Zuidmeer L
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2005 | Germany | HRT | 20 | 75.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2005 | Germany | IgE | 20 | 60.000 | | | 5.1.1 - Source Exposed (Symptoms) | 2003 | Denmark | HRT | 10 | 70.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1995 | Austria | IgE | 9 | 100.000 | |
|
Loading...
Mal d 1
